1747
Within 3 days after starting bismuth subsalicylate therapy, the patient's INR increased from 2.56 to 3.54 and minor bleeding was noted from the patient's tracheostomy site.
 the patient: Subject; INR increased from 2.56 to 3.54 and minor bleeding was noted from the patient's tracheostomy site: Effect; Within 3 days after starting bismuth subsalicylate therapy: Treatment; 3 days: Treatment.Duration; bismuth subsalicylate: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 the patient: Subject; INR increased from 2.56 to 3.54 and minor bleeding was noted from the patient's tracheostomy site: Effect; Within 3 days after starting bismuth subsalicylate therapy: Treatment; 3 days: Treatment.Duration; bismuth subsalicylate: Treatment.Drug